Ventas price target lowered to $68 from $71 at Mizuho

Mizuho analyst Vikram Malhotra lowered the firm’s price target on Ventas (VTR) to $68 from $71 and keeps an Outperform rating on the shares. The firm says that despite healthcare real estate investment trusts’ outperformance in fiscal 2024, it continues to like the subsector into fiscal 2025, but feels “some rotation is warranted. Mizuho reiterates a positive stance on senior housing and shifted to neutral from positive on the skilled nursing facility group. It recommends rotating into life sciences as it sees venture funding improving through the year.